Translating evidence into global impact: lessons for HIV research and policy development from the AMBITION trial.
Jarvis, JN
; Chou, R; Harrison, TS; Lawrence, DS; Muthoga, C; Mupeli, K; Meya, DB; Mwandumba, HC; Kanyama, C; Meintjes, G; +7 more...Leeme, TB; Ndhlovu, CE; Beattie, P; Sued, O; Pérez Casas, C; Makanga, M; Ford, N and
(2023)
Translating evidence into global impact: lessons for HIV research and policy development from the AMBITION trial.
The Lancet Global health, 11 (11).
e1688-e1690.
ISSN 2214-109X
DOI: 10.1016/S2214-109X(23)00412-6
; Chou, R; Harrison, TS; Lawrence, DS; Muthoga, C; Mupeli, K; Meya, DB; Mwandumba, HC; Kanyama, C; Meintjes, G; +7 more...Leeme, TB; Ndhlovu, CE; Beattie, P; Sued, O; Pérez Casas, C; Makanga, M; Ford, N and
(2023)
Translating evidence into global impact: lessons for HIV research and policy development from the AMBITION trial.
The Lancet Global health, 11 (11).
e1688-e1690.
ISSN 2214-109X
DOI: 10.1016/S2214-109X(23)00412-6
Translating evidence from clinical trials to routine care can take many years, particularly in low-income and middle-income countries, delaying access to lifesaving or life-changing treatments. As few as one in five evidence-based health interventions are incorporated into routine use, and the average time lag between evidence availability and practice change is up to 17 years.
-
picture_as_pdf - Jarvis-etal-2023-Translating-evidence-into-global-impact.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 4.0
Downloads